HSA-coated intrinsically radiolabeled [177Lu]Lu₂O₃ nanoparticles for injectable nanoscale brachytherapy: Preclinical validation and first-in-human imaging
Nanomedicine: Nanotechnology, Biology and Medicine
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
HSA-coated intrinsically radiolabeled [177Lu]Lu₂O₃ nanoparticles for injectable nanoscale brachytherapy: Preclinical validation and first-in-human imaging. // Nanomedicine: Nanotechnology, Biology and Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S1549963426001516?dgcid=rss_sd_all
HSA-coated intrinsically radiolabeled [177Lu]Lu₂O₃ nanoparticles for injectable nanoscale brachytherapy: Preclinical validation and first-in-human imaging. Nanomedicine: Nanotechnology, Biology and Medicine. https://www.sciencedirect.com/science/article/pii/S1549963426001516?dgcid=rss_sd_all
“HSA-coated intrinsically radiolabeled [177Lu]Lu₂O₃ nanoparticles for injectable nanoscale brachytherapy: Preclinical validation and first-in-human imaging.” Nanomedicine: Nanotechnology, Biology and Medicine.
@article{article59654,
title = {HSA-coated intrinsically radiolabeled [177Lu]Lu₂O₃ nanoparticles for injectable nanoscale brachytherapy: Preclinical validation and first-in-human imaging},
journal = {Nanomedicine: Nanotechnology, Biology and Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S1549963426001516?dgcid=rss_sd_all}
}